Publications

5808 Results

The Prostate Cancer Prevention Trial and the future of chemoprevention. PMID: 18353157

Authors
IM Thompson;CM Tangen;MS Lucia
Journal / Conference
British Journal of Urology International 101(8):933-934
Year
2008
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

Southwest Oncology Group phase II trial (S0341) of erlotinib (OSI-774) in patients with advanced non-small cell lung cancer and a performance status of 2 [PMID18758306; PMC3523698]

Authors
PJ Hesketh;K Chansky;AJ Wozniak;FR Hirsch;A Spreafico;J Moon;PC Mack;BT Marchello;WA Franklin;JJ Crowley;DR Gandara
Journal / Conference
Journal of Thoracic Oncology 3(9):1026-1031
Year
2008
Research Committee(s)
Lung
Study Number(s)
S0341

Association of family history with cancer recurrence and survival among patients with stage III colon cancer [PMID18523220; NIHMS277201]

Authors
JA Chan;JA Meyerhardt;D Niedzwiecki;D Hollis;LB Saltz;RJ Mayer;J Thomas;PL Schaefer;R Whittom;A Hantel;RM Goldberg;RS Warren;M Bertagnolli;C Fuchs
Journal / Conference
Journal of the American Medical Association 299(21):2515-2523
Year
2008
Research Committee(s)
Gastrointestinal
Study Number(s)
C89803

Pathologic characteristics of cancers detected in the Prostate Cancer Prevention Trial: implications for prostate cancer detection and chemoprevention

Authors
MS Lucia;A Darke;P Goodman;FG La Rosa;HL Parnes;LG Ford;CA Coltman;IM Thompson
Journal / Conference
Cancer Prevention Research 1(3):167-173
Year
2008
Research Committee(s)
Cancer Control
PMID
PMID19138952
PMC
NIHMSID551895
Study Number(s)
SWOG-9217

Finasteride does not increase the risk of high-grade prostate cancer: a bias-adjusted modeling approach

Authors
M Redman;C Tangen;P Goodman;MS Lucia;CA Coltman;IM Thompson
Journal / Conference
Cancer Prevention Research 1(3):174-181
Year
2008
Research Committee(s)
Cancer Control
PMID
PMID: 19138953
PMC
PMC2844801
Study Number(s)
SWOG-9217

Phase II Southwest Oncology Group study of docetaxel and vinorelbine plus filgrastim with weekly trastuzumab for HER2-positive, stage IV breast cancer

Authors
J Kash;WE Barlow;KS Albain;JR Gralow;D Lew;LE Flaherty;ME Royce;GN Hortobagyi;RB Livingston
Journal / Conference
Journal of Clinical Oncology 26(15S):49s, #1033
Year
2008
Research Committee(s)
Breast
Study Number(s)
S0215

Weekly paclitaxel in the adjuvant treatment of breast cancer [PMC2743943; PMID18420499]

Authors
JA Sparano;M Wang;S Martino;V Jones;EA Perez;TJ Saphner;AC Wolff;GW Sledge;WC Wood;NE Davidson
Journal / Conference
New England Journal of Medicine 358(16):1663-1771
Year
2008
Research Committee(s)
Breast
Study Number(s)
E1199

NSABP B30: Definitive analysis of patient outcome from a randomized trial evaluating different schedules and combinations of adjuvant therapy containing doxorubicin, docetaxel and cyclophosphamide in women with operable, node-positive breast cancer.

Authors
SM Swain;HJ Jeong;CE Geyer;JP Costantino;ER Pajon;L Fehrenbacher;JN Atkins;JA Polikoff;VG Vogel;JK Erban;RB Livingston;E Perez;EP Mamounas;PA Ganz;SR Land;N Wolmark
Journal / Conference
San Antonio Breast Cancer Symposium, abstract #75
Year
2008
Research Committee(s)
Breast

Arsenic trioxide consolidation improves event-free and overall survival among patients with newly diagnosed acute promyelocytic leukemia: North American Intergroup protocol C9710

Authors
BL Powell;B Moser;W Stock;RE Gallagher;CL Willman;RM Stone;JM Rowe;SE Coutre;JH Feusner;J Gregory;S Couban;FR Appelbaum;MS Tallman;RA Larson
Journal / Conference
Annals of Hematology 87(Suppl. 1):S77-S78
Year
2008
Research Committee(s)
Leukemia
Study Number(s)
C9710

Progress in small cell lung cancer: the lowest common denominator [PMID18779609]

Authors
DR Gandara;PN Lara, Jr.;RB Natale;C Belani
Journal / Conference
Journal of Clinical Oncology 26(26):4236-4238
Year
2008
Research Committee(s)
Lung
Study Number(s)
S0124